Résultats de la recherche - 9 results
Clustering of Tadalafil API Samples According to their Manufacturer in the Context of API Falsification Detection
fingerprint GEON/OMCL network illegal medicinal products Tadalafil Abstract: This paper reports the results of the active pharmaceutical ingredient (API) fingerprint study, organised by the General European ...
Relative response factors and multiple regression models in liquid chromatography to quantify low-dosed components using alternative standards-proof of concept: total Δ9-THC content in cannabis flowers using CBD as reference.
the concentration around 0.2% (w/w) total Δ9- THC, the legal limit (in most European countries) in these products. Results showed that the newly presented and validated LRRFM approach outperformed the ...
GEONs API fingerprint project: Selection of analytical techniques for clustering of sildenafil citrate API samples
Abstract: Through its Active Pharmaceutical Ingredient Working Group (API- WG) the General European Official Medicines Control Laboratory (OMCL) Network (GEON), co-ordinated by the European Directorate for ...
European fingerprint study on omeprazole drug substances using a multi analytical approach and chemometrics as a tool for the discrimination of manufacturing sources
substances and prevent the use of non-compliant API s, Official Medicine Control Laboratories work together in a European network developing coordinated strategies and programmes. The API working group ...
Characterization and risk identification of falsified medicines and adulterated dietary supplements
selectivity and specificity for the detection of targeted plants in mixtures. It stands to reason that collaborations on these topics would be beneficial for both the European and the Chinese policy makers to ...
The occurrence of non-anatomical therapeutic chemical-international nonproprietary name molecules in suspected illegal or illegally traded health products in Europe: A retrospective and prospective study.
The General European Official Medicines Control Laboratory (OMCL) Network (GEON), co-ordinated by the European Directorate for the Quality of Medicines & HealthCare (EDQM), regularly organises ...
The occurrence of putative cognitive enhancing research peptides in seized pharmaceutical preparations: An incentive for controlling agencies to prepare for future encounters of the kind.
recommendation paper of the General European Official Medicines Control Laboratory (OMCL) network on the interpretation of screening results for unknown peptides by mass spectrometry, was also validated in ...
API Testing: how OMCLs can support the control of APIs
Publication Type: Scientific poster, presentation or proceeding Authors: Eric Deconinck; Yvan Grange Source: EDQM and European Pharmacopoeia: State-of-the-art Science for Tomorrow’s Medicines, EDQM, ...
Analysis of illegal peptide drugs via HILIC-DAD-MS.
an analytical method based on hydrophilic interaction liquid chromatography (HILIC) to identify and quantify the most frequently encountered illegal peptides on the European market. For this objective, ...